|
Volumn 320, Issue 5, 2018, Pages 499-500
|
Probiotics to prevent Clostridium difficile infection in patients receiving antibiotics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
PLACEBO;
PROBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ABDOMINAL CRAMP;
BACTERIAL STRAIN;
CLOSTRIDIUM DIFFICILE INFECTION;
DIARRHEA;
DISEASE ASSOCIATION;
DRUG USE;
HIGH RISK POPULATION;
HOSPITAL PATIENT;
HUMAN;
INFECTION PREVENTION;
INFECTION RISK;
NAUSEA;
NONHUMAN;
OUTPATIENT;
POST HOC ANALYSIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SHORT SURVEY;
SIDE EFFECT;
ADULT;
CHILD;
CLOSTRIDIUM INFECTION;
IMMUNOCOMPROMISED PATIENT;
LITERATURE;
PEPTOCLOSTRIDIUM DIFFICILE;
ADULT;
ANTI-BACTERIAL AGENTS;
CHILD;
CLOSTRIDIUM DIFFICILE;
CLOSTRIDIUM INFECTIONS;
HUMANS;
IMMUNOCOMPROMISED HOST;
PRACTICE GUIDELINES AS TOPIC;
PROBIOTICS;
REVIEW LITERATURE AS TOPIC;
|
EID: 85051979016
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2018.9064 Document Type: Short Survey |
Times cited : (62)
|
References (4)
|